Acción ORIAU ORION BIOTECH OPPORTUNITIES CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Orion Biotech Opportunities Corp. OTC Markets

Acciones

ORIAU

KYG6780C1252

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Orion Biotech Opportunities Corp.(OTCPK:ORIA) dropped from NASDAQ Composite Index
Orion Biotech Opportunities : will redeem its Public Shares and will not consummate an initial business combination - Form 8-K
ORION BIOTECH OPPORTUNITIES CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Auditor Raises 'Going Concern' Doubt
Orion Biotech Opportunities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Orion Biotech Opportunities Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
ORION BIOTECH OPPORTUNITIES CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
Orion Biotech Opportunities Corp. Reports Earnings Results for the Eleven Months Ended December 31, 2021
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q/A)
ORION BIOTECH OPPORTUNITIES CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
ORION BIOTECH OPPORTUNITIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Certain Class B Ordinary Shares of Orion Biotech Opportunities Corp. are subject to a Lock-Up Agreement Ending on 9-NOV-2021.
ORION BIOTECH OPPORTUNITIES : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Orion Biotech Opportunities Corp. has completed an IPO in the amount of $200 million.
Orion Biotech Opportunities Corp. has filed an IPO in the amount of $200 million.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción ORIA
  4. Acción ORIAU
  5. Noticias Orion Biotech Opportunities Corp.
  6. Otros idiomas